AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,832,031 | +176.3% | 75,613 | +59.9% | 0.33% | +233.3% |
| Q3 2022 | $2,111,000 | -23.0% | 47,300 | -33.9% | 0.10% | -11.6% |
| Q2 2022 | $2,742,000 | +177.2% | 71,600 | +199.6% | 0.11% | +211.1% |
| Q1 2022 | $989,000 | -63.3% | 23,900 | -66.5% | 0.04% | -62.5% |
| Q4 2021 | $2,692,000 | +48.4% | 71,249 | +29.5% | 0.10% | +24.7% |
| Q3 2021 | $1,814,000 | +340.3% | 55,038 | +802.3% | 0.08% | +352.9% |
| Q2 2021 | $412,000 | -36.7% | 6,100 | -47.0% | 0.02% | -37.0% |
| Q1 2021 | $651,000 | -43.3% | 11,500 | -18.4% | 0.03% | -40.0% |
| Q4 2020 | $1,149,000 | +15.9% | 14,100 | +1.4% | 0.04% | -4.3% |
| Q3 2020 | $991,000 | -72.3% | 13,900 | -68.0% | 0.05% | -76.7% |
| Q2 2020 | $3,578,000 | +316.0% | 43,491 | +197.9% | 0.20% | +201.5% |
| Q1 2020 | $860,000 | -96.8% | 14,600 | -94.4% | 0.07% | -95.5% |
| Q4 2019 | $26,762,000 | – | 258,948 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |